CD62L and CD31 matching are independent risk factors for survival after bone marrow transplantation. Yu, W., Hiraki, D., Sequiera, J., Negrin, R., Grumet, F. C., Lowsky, R. AMER SOC HEMATOLOGY. 2005: 411A

View details for Web of Science ID 000233426002358